Federation Des Caisses Desjardins Du Quebec Neogenomics Inc Transaction History
Federation Des Caisses Desjardins Du Quebec
- $18.9 Billion
- Q3 2024
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Neogenomics Inc stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 700 shares of NEO stock, worth $10,339. This represents 0.0% of its overall portfolio holdings.
Number of Shares
700
Previous 700
-0.0%
Holding current value
$10,339
Previous $9,000
11.11%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding NEO
# of Institutions
292Shares Held
124MCall Options Held
698KPut Options Held
120K-
Black Rock Inc. New York, NY19.7MShares$291 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$207 Million0.0% of portfolio
-
Brown Advisory Inc6.89MShares$102 Million0.13% of portfolio
-
Janus Henderson Group PLC London, X06.6MShares$97.5 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.54MShares$96.6 Million0.06% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.86B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...